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drug reaction (286.51.2%), but even in case
of asthma (282, 50.5%), food allergy (62,
11.1%) and latex allergy (12, 2.15%).No
serious adverse event has occurred in
patients we examined.
Conclusions: Our data show the importance
of the presence of Allergy Units in Hospital
and emphasise the growing attention on the
allergologic diseases in obstetric gynaecolo-
gical field.
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Background: Adverse drug reactions
(ADRs) are extremely common, but there
are no national studies in Portugal. Studies
in other parts of the world indicate an
incidence of about 8%. Our aim was to
evaluate the incidence of ADRs and to
characterize them in adults observed in
consultations from different specialities.
Methods: Questionnaires regarding adverse
drug reactions were randomly given to 30
patients attending consultations from differ-
ent specialities: Immunoallergology, Obste-
trics, Internal Medicine and Dermatology
(120 total). Patients attending the drug
allergy consultation were excluded. No
other exclusion criteria were used. The
questionnaire was made by the Drug hyper-
sensitivity interest group of the Portuguese
Society of Allergology and Clinical Immu-
nology (SPAIC) and included 17 questions
in order to adequately characterize the
ADRs the patients had experienced, if any,
specifically to the culprit drug, their symp-
toms and onset, the administration method,
treatment, as well as concomitant adminis-
tration of other drugs. Personal and family
history of atopy and allergic drug reactions
were also asked about.
Results: One hundred and twenty patients
(72.5%F) answered the questionnaire. The
mean age was 40.87 18 years. 80.8% denied
ever having an ADR. Regarding the remain-
ing, 8 reported having skin symptoms (rash,
urticaria, angioedema), 3 gastro-intestinal
symptoms (vomiting, abdominal cramps,
diarrhoea), 9 respiratory symptoms (sneez-
ing, dyspnoea, glottis oedema). Finally, 7
patients reported other complaints (tachy-
cardia, dizziness, etc.). Five patients impli-
cated beta-lactams and other 5 NSAIDs as
the culprit drug. 8 patients were also taking
other drugs at the time, and 6 had some kind
of infection or high temperature. Eighteen
patients took the drug in the form of a pill,
while 5 patients had the drug administered
via parenteric route. Nine patients had an
immediate reaction. Thirteen patients had to
seek medical assistance. The mean age at the
time of the ADR was 317 14 years. Twelve
patients had a personal history of allergic
disease, 12 a family history of allergic
disease and 6 a family history of drug
allergy.
Conclusion: The incidence of ADRs in our
population was similar to that reported in
the general population. Most of the reac-
tions reported were, however, possibly
allergic in nature. Many of these were
considered mild, with 43% of the patients
not seeking medical attention. However, 2
patients described what can be considered as
anaphylactic reactions.
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Rationale: Non-immediate allergic reactions
to iodine contrast media (ICM) represent 2–
5% of patients with adverse reactions to
ICM. Although these reactions are T cell
mediated, the lymphocyte transformation
test (LTT) is frequently negative. We com-
pared the LTT to ICM using either B
lymphocytes and monocytes (B linf/mo:
classical LTT) or Dendritic Cells (DC) as
antigen presenting cells.
Methods: Peripheral blood lymphocytes
and immature monocyte-derived DCs
(imDC) were obtained from 4 patients with
non-immediate allergy to iodixanol and 4
tolerant subjects. B linf/mo or imDCs were
cultured with lymphocytes and different
ICM (iodixanol, iomeprol, ioversol and
meglumene ioxaglate) and lymphocyte pro-
liferation was analyzed by means of H3-T
incorporation. The stimulation index (SI)
3 was considered a positive response.
Results: Classical LTT (B linf/mo) was
negative in 3 patients with all ICM analyzed
and positive to iodixanol in case 4
(SI5 3.32). However, LTT with imDCs
showed a positive proliferation to iodixanol
in all 4 cases (case 1: SI5 5.74; case 2:
SI5 10.55; case 3: SI5 6.69; case 4:
SI5 17.39), with different degrees of cross
reactivity with other ICM. Both tests were
negative in controls with all the ICM tested.
Conclusions: Proliferative responses to the
culprit ICM were detected in patients with
non immediate allergic reactions to iodix-
anol, suggesting that a specific immunolo-
gical mechanism takes part. However, the
fact that proliferative responses were mostly
observed when DC were used emphasize the
importance of these antigen presenting cells
in the development of allergic responses to
ICM.
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Background: Hypersensitivity to contrast
media (CM) is quite common and a serious
problem. However there is no data about
the prevalence of CM-induced reactions in
Turkey. In this study we aimed to evaluate;
the prevalence, types and risk factors
associated with CM-induced reactions, and
diagnostic role of skin testing in these
reactions.
Method: A total of 1131 patients (F/M: 501/
630, mean age: 557 14.2 years) recruited
from radiology department were conse-
quently included into the study. All patients
were questioned about current or past CM-
induced reactions besides demographic and
clinical evaluation. Patients with early and
delayed type reactions to CM underwent
skin testing including prick test, intradermal
test and patch test with implicated CM.
Fifteen age and gender matched patients
who tolerated CM served as control group.
Data were compared between patients with
CM sensitivite and tolerant.
Results: The prevalence of past reaction to
CM was 2.9% (n: 33) early reaction in 21
(63%) and late reaction in 12 (37%).
Twenty-six of the past reactors underwent
radiological evaluation without CM and 7
were premedicated before evaluation. A
total of 1105 patients received non-ionic
monomer or dimer CM via intravascular
route. The most preferred agent was iohexol
(n: 784, 69.3%). The prevalence of sensitiv-
ity to CM was 0.7% (n: 8), during the
current radiological evaluation. Considering
past and current reactions, the total pre-
valence of sensitivite to CM was 3.62% (n:
41). As current sensitivity reaction, 4
patients developed early reactions (0.35%)
(Grade 1–2) and 4 delayed type reactions
(mild-moderate) (0.35%). The most fre-
quently reported symptoms were itching
and urticaria as early or delayed type
reactions. No hospitalization and mortality
observed. Women gender, asthma, drug or
food allergy and psychiatric diseases were
found as significant risk factors associated
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